10.12.2012 Views

Abstracts (complete list) - Wissenschaft Online

Abstracts (complete list) - Wissenschaft Online

Abstracts (complete list) - Wissenschaft Online

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Manuela Hessmann, Dominik Rueckerl, Toshiyuki Takai, Stefan Ehlers, Christoph<br />

Hoelscher<br />

The ITAM-bearing adapter protein DAP12 modulates<br />

inflammatory immune responses after Mycobacterium<br />

tuberculosis infection<br />

Activation of the innate immune system leads to the release of pro-inflammatory<br />

cytokines and is considered to be a prerequisite for driving a protective adaptive<br />

immune response after infection. However, inflammatory immune responses may also<br />

lead to tissue destruction and regulatory mechanisms are necessary to prevent<br />

uncontrolled inflammation. Hence, activating and inhibitory host factors are required in<br />

order to balance protection and immunopathology. When associated with different<br />

receptors, the ITAM-containing signalling adaptor DAP12 (DNAX activating protein of 12<br />

kDa) has been shown to affect inflammatory immune responses.<br />

To analyse the influence of DAP12 on cell-mediated immune responses during<br />

mycobacterial infection we infected DAP12-deficient (KO) mice with Mycobacterium<br />

tuberculosis. In contrast to wildtype mice, infection of DAP12 KO animals resulted in<br />

increased inflammatory immune response. In the absence of DAP12, the expansion of<br />

activated T cells was enhanced accompanied with elevated antigen-specific effector<br />

functions. On the cellular level, we could show that DAP12 KO macrophages<br />

overproduce pro-inflammatory cytokines in response to M. tuberculosis infection.<br />

In summary, we assume DAP12-dependent pathways in macrophages to modulate<br />

inflammatory immune responses during mycobacterial infection. These signalling<br />

pathway may represent novel target in order to mitigate chronic inflammation in human<br />

tuberculosis.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!